Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation

Laboratory Investigation

Volumn 84, Issue 4, 2004, Pages 406-417

  Edsjö, Anders ^a   Nilsson, Helén ^a   Vandesompele, Jo ^b   Karlsson, Jenny ^a   Pattyn, Filip ^b   Culp, Lloyd A ^c   Speleman, Frank ^b   Påhlman, Sven ^a  

^a LUND UNIVERSITY   (Sweden)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Development; Differentiation; MYCN; Neuroblastoma; Sympathetic nervous system

Indexed keywords

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE CELL DIFFERENTIATION; NEUROBLAST; NEUROBLASTOMA; NORTHERN BLOTTING; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING; ADRENERGIC SYSTEM; CELL DIFFERENTIATION; DRUG EFFECT; GENETICS; METABOLISM; NERVE CELL; ONCOGENE MYC; PATHOLOGY; PHYSIOLOGY;

BRAIN DERIVED NEUROTROPHIC FACTOR; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENES, MYC; HUMANS; NEUROBLASTOMA; NEURONS; SYMPATHETIC NERVOUS SYSTEM; TETRADECANOYLPHORBOL ACETATE; TRETINOIN;

EID: 2342614314     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700061     Document Type: Article

References (65)

1. Schwab M, Schwab M, Alitalo K, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983;305:245-248.
2. Kohl NE, Kanda N, Schreck RR, et al. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 1983;35:359-367.
3. Kohl NE, Gee CE, Alt FW. Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science 1984;226:1335-1337.
4. Schwab M, Ellison J, Busch M, et al. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 1984;81:4940-4944.
5. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-1124.
6. Brodeur GM, Ambros PF. Genetic and biological markers of prognosis in neuroblastoma. In: Brodeur GM, Sawada T, Tsuchida Y, Voütes PA (eds) Neuroblastoma. Elsevier Science B.V.: Amsterdam, The Netherlands, 2000, pp. 355-369.
7. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-1116.
8. Weiss WA, Aldape K, Mohapatra G, et al. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997;16:2985-2995.
9. Wartiovaara K, Barnabe-Heider F, Miller FD, et al. N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons. J Neurosci 2002;22:815-824.
10. Lutz W, Stohr M, Schurmann J, et al. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 1996;13:803-812.
11. Boon K, Caron HN, van Asperen R, et al. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J 2001;20:1383-1393.
12. Sawai S, Kato K, Wakamatsu Y, et al. Organization and expression of the chicken N-myc gene. Mol Cell Biol 1990;10:2017-2026.
13. Kato K, Kanamori A, Wakamatsu Y, et al. Tissue distribution of N-myc expression in the early organogenesis period of the mouse embryo. Dev Growth Differ 1991;33:29-36.
14. Jakobovits A, Schwab M, Bishop JM, et al. Expression of N-myc in teratocarcinoma stem cells and mouse embryos. Nature 1985;318:188-191.
15. Mugrauer G, Alt FW, Ekblom P. N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J Cell Biol 1988;107:1325-1335.
16. Wakamatsu Y, Watanabe Y, Nakamura H, et al. Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Development 1997;124:1953-1962.
17. Sawai S, Shimono A, Wakamatsu Y, et al. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 1993;117:1445-1455.
18. Thiele CJ, Israel MA. Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. Exp Cell Biol 1988;56:321-333.
19. Peverali FA, Orioli D, Tonon L, et al. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene 1996;12:457-462.
20. Hedborg F, Bjelfman C, Sparen P, et al. Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome. Eur J Cancer 1995;4:435-443.
21. Nisen PD, Waber PG, Rich MA, et al. N-myc oncogene RNA expression in neuroblastoma. J Natl Cancer Inst 1988;80:1633-1637.
22. Seeger RC, Wada R, Brodeur GM, et al. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 1988;271:41-49.
23. Slavc I, Ellenbogen R, Jung WH, et al. myc gene amplification and expression in primary human neuroblastoma. Cancer Res 1990;50:1459-1463.
24. Chan HS, Gallie BL, DeBoer G, et al. MYCN protein expression as a predictor of neuroblastoma prognosis. Clin Cancer Res 1997;3:1699-1706.
25. Bordow SB, Norris MD, Haber PS, et al. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol 1998;16:3286-3294.
26. Cohn SL, Ikegaki N. Expression of MYCN mRNA and protein. In: Brodeur GM, Sawada T, Tsuchida Y, Voütes PA (eds). Neuroblastoma. Elsevier Science B.V.: Amsterdam, The Netherlands, 2000, pp. 137-146.
27. Judware R, Culp LA. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit. Oncogene 1995;11:2599-2607.
28. Øra I, Bondesson L, Jonsson C, et al. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Biochem Biophys Res Commun 2000;277:179-185.
29. Ohlsson R, Holmgren L, Glaser A, et al. Insulin-like growth factor 2 and short-range stimulatory loops in control of human placental growth. EMBO J 1989;8:1993-1999.
30. Durbeej M, Söderström S, Ebendal T, et al. Differential expression of neurotrophin receptors during renal development. Development 1993;119:977-989.
31. Örtoft E, Påhlman S, Andersson G, et al. Human GAP-43 expression: multiple start sites for initiation of transcription in differentiating human neuroblastoma cells. Mol Cell Neurosci 1993;4:549-561.
32. Tso JY, Sun XH, Kao TH, et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13:2485-2502.
33. Grynfeld A, Påhlman S, Axelson H. Induced neuroblastoma cell differentiation, associated with transient HES-1 activity and reduced HASH-1 expression, is inhibited by Notch1. Int J Cancer 2000;88:401-410.
34. Minth CD, Andrews PC, Dixon JE. Characterization, sequence, and expression of the cloned human neuropeptide Y gene. J Biol Chem 1986;261:11974-11979.
35. Vandesompele J, De Paepe A, Speleman F. Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal Biochem 2002;303:95-98.
36. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3, RESEARCH0034.
37. Pattyn F, Speleman F, De Paepe A, et al. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res 2003;31:122-123.
38. Hoehner JC, Gestblom C, Hedborg F, et al. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest 1996;75:659-675.
39. Gestblom C, Hoehner JC, Hedborg F, et al. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas. Am J Pathol 1997;150:107-117.
40. Gestblom C, Hoehner JC, Hedborg F, et al. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas. Lab Invest 1999;79:67-79.
41. Bjelfman C, Hedborg F, Johansson I, et al. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis. Cancer Res 1990;50:6908-6914.
42. Cohn SL, London WB, Huang D, et al. MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN. J Clin Oncol 2000;18:3604-3613.
43. Breit S, Schwab M. Suppression of MYC by high expression of NMYC in human neuroblastoma cells. J Neurosci Res 1989;24:21-28.
44. Vandesompele J, Edsjö A, De Preter K, et al. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene 2003;22:456-460.
45. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973;33:2643-2652.
46. Breit S, Ashman K, Wilting J, et al. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res 2000;60:4596-4601.
47. Judware R, Culp LA. Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of alpha2, alpha3 and beta1. Oncogene 1997;14:1341-1350.
48. Judware R, Culp LA. Persistent alpha1 integrin subunit expression in human neuroblastoma cell lines which overexpress N-myc and downregulate other integrin subunits. Oncol Rep 1997;4:433-437.
49. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 1983;71:741-747.
50. Påhlman S, Odelstad L, Larsson E, et al. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13- acetate. Int J Cancer 1981;28:583-589.
51. Påhlman S, Ruusala AI, Abrahamsson L, et al. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 1984;14:135-144.
52. Adem A, Mattsson ME, Nordberg A, et al. Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res 1987;430:235-242.
53. Edsjö AA, Lavenius E, Nilsson H, et al. Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment. Lab Invest 2003;83:813-823.
54. Bjelfman C, Meyerson G, Cartwright CA, et al. Early activation of endogenous pp60src kinase activity during neuronal differentiation of cultured human neuroblastoma cells. Mol Cell Biol 1990;10:361-370.
55. Kaplan DR, Matsumoto K, Lucarelli E, et al. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron 1993;11:321-331.
56. Lavenius E, Parrow V, Nånberg E, et al. Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture. Growth Factors 1994;10:29-39.
57. Jensen LM. Phenotypic differentiation of aphidicolin-selected human neuroblastoma cultures after long-term exposure to nerve growth factor. Dev Biol 1987;120:56-64.
58. LoPresti P, Poluha W, Poluha DK, et al. Neuronal differentiation triggered by blocking cell proliferation. Cell Growth Differ 1992;3:627-635.
59. Poluha W, Poluha DK, Ross AH. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene 1995;10:185-189.
60. Jögi A, Øra I, Nilsson H, et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002;99:7021-7026.
61. Guillemot F, Joyner AL. Dynamic expression of the murine Achaete-Scute homologue Mash-1 in the developing nervous system. Mech Dev 1993;42:171-185.
62. Bogenmann E, Torres M, Matsushima H. Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation. Oncogene 1995;10:1915-1925.
63. Rettig WJ, Spengler BA, Chesa PG, et al. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res 1987;47:1383-1389.
64. Knoepfler PS, Cheng PF, Eisenman RN. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 2002;16:2699-2712.
65. Malynn BA, de Alboran IM, O'Hagan RC, et al. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 2000;14:1390-1399.